EMA Issues Advice for Potential Early Use of Pfizer's Novel COVID-19 Oral Antiviral Candidate Pharmaceutical Investing
ADDING and REPLACING European Commission Approves Merck's VAXNEUVANCE for Individuals 18 Years of Age and Older Pharmaceutical Investing
Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine Pharmaceutical Investing
European Commission Approves Merck's VAXNEUVANCE for Individuals 18 Years of Age and Older Pharmaceutical Investing
Arena Pharmaceuticals INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA Life Science Investing
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States Pharmaceutical Investing
U.S. FDA Approves Pfizer's XELJANZ® for the Treatment of Active Ankylosing Spondylitis Pharmaceutical Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Arena Pharmaceuticals Inc. Buyout Life Science Investing
